Purchase Order 75D30125P20390
Award Date
12/19/24
Potential Completion Date
12/18/29
Potential Value
$59K
Federal Agency
CDC Pittsburgh
Awardee
Quanterix Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
DA10 - It And Telecom - Business Application/Application Development Software As A Service
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention's (CDC) Pittsburgh office to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $160,091.47 contract is for the identification of biomarkers for occult diseases, with a completion date of October 27, 2023. Quanterix, the prime contractor, provides advanced instruments, assay kits, and research services to federal government...
This federal contract award, with ID HHSN263201600011A, was issued by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Quanterix Corporation, a for-profit manufacturer of goods. The $112,000.00 firm-fixed-price purchase order is for service-related work, with an ultimate completion date of October 19, 2020. Quanterix Corporation specializes in ultra-sensitive digital biomarker detection technology, providing advanced instruments, assay kits, and research services...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Quanterix Corporation for a Quanterix SR-X Ultra-Sensitive Biomarker Detection System and related equipment and services. The total ceiling value of the contract is $89,500.00. This award is not associated with a set-aside program. Quanterix Corporation is a life sciences company that specializes in ultra-sensitive...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
Quanterix Corporation has been awarded a firm fixed price purchase order by the National Institutes of Health National Institute on Aging totaling $12,800.88. The contract has no set-aside designation. Under this award, Quanterix will provide its single molecule array platform and associated assay kits and reagents to support the agency's biomarker detection research efforts. Additionally, Quanterix holds an indefinite delivery contract from the Department of Veterans Affairs Veterans Health...
This firm-fixed-price purchase order was awarded by the National Institute of Nursing Research (NINR), a civilian agency under the National Institutes of Health (NIH), to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $3,070.94 contract is for the procurement of Quanterix's Simoa (single molecule array) biomarker detection equipment and related maintenance services. Quanterix has received multiple federal contract awards...
This is a firm-fixed-price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Quanterix Corporation, a manufacturer of advanced biomarker detection technology. The $84,525 contract supports Quanterix's work on the Rapid Acceleration of Diagnostics (RADx) initiative for COVID-19 testing. Quanterix is providing specialized Simoa instruments, assay kits, and research services to federal agencies like the NIH,...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order to Quanterix Corporation, a for-profit life sciences company, for a QUANTERIX SP - X IMAGING ANALYSIS SYSTEM valued at $147,321.00. This award, which does not have a set-aside designation, supports the agency's efforts related to the COVID-19 national interest action. Quanterix has received over $30 million in prior federal contracts from agencies including the NIH, VA, and DoD to supply its Simoa...